GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
dc.identifier.other
WOS:000631349602018
dc.description.volume
dc.description.issue
Publisher
ELSEVIER SCIENCE INC
